OMER

Maxim Group analyst Jason McCarthy maintained a Hold rating on Omeros (OMER - Research Report) yesterday. The company's shares closed yesterday at $7.13.According to TipRanks, McCarthy is an analyst with an average return of -37.6% and a 16.55% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as SELLAS Life Sciences Group, Atossa Therapeutics, and Capricor Therapeutics.Currently, the analyst consensus on Omeros is a Hold with an average price target of $4.00.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $16.57 and a one-year low of $1.86. Currently, Omeros has an average volume of 1.48M.
https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-omeros-omer?utm_source=advfn.com&utm_medium=referral